Bellevue Life Sciences Acquisition Corp. announced a private placement of unsecured promissory note for the gross proceeds of $50,000 on April 17, 2024. The transaction included participation from returning lender Bellevue Global Life Sciences Investors, LLC.

The note is not interest bearing and is payable in full on the earlier of December 31, 2024 or the date on which the company consummates an initial business combination.